Low dose immunosuppression for septic liver transplantation patients
Hart, M.E.; Foster, P.F.; Sankary, H.N.; Ashmann, M.; Williams, J.W.
Transplantation Proceedings 21(1 Part 2): 2234-2235
1989
ISSN/ISBN: 0041-1345 PMID: 2652723 Document Number: 335001
Document emailed within 1 workday
Related Documents
Tsai, M.-K.; Hu, R.-H.; Lee, C.-J.; Lee, P.-H. 2002: Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression Journal of the Formosan Medical Association 101(9): 616-621Stephens, J.; Goldstein, R.; Crippin, J.; Husberg, B.; Holman, M.; Gonwa, T.A.; Klintmalm, G. 1993: Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients Transplantation Proceedings 25(1 Part 2): 1122-1123
Winkler, M.; Ringe, B.; Jost, U.; Gubernatis, G.; Pichlmayr, R. 1993: Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation Transplantation Proceedings 25(4): 2688-2690
Gulanikar, A.C.; Kotylak, G.; Bitter-Suermann, H. 1991: Does immunosuppression alter the growth of metastatic liver carcinoid after orthotopic liver transplantation? Transplantation Proceedings 23(4): 2197-2198
Everson, G.T.; Trotter, J.F.; Kugelmas, M.; Forman, L. 2003: Immunosuppression in liver transplantation Minerva Chirurgica 58(5): 725-740
Selvaggi, G.; Ricordi, C.; Bottino, R.; Tzakis, A.G. 1996: Liver transplantation without immunosuppression: future perspectives Italian Journal of Gastroenterology 28(4): 246-249
Rasmussen, A.; Hjortrup, A.; Hansen, B.; Heslet, L.; Kirkegaard, P. 1996: Induction of immunosuppression by microemulsion cyclosporine in liver transplantation Transplantation 62(7): 1031-1033
Fung, J.; Todo, S.; Abu-Elmagd, K.; Jain, A.; Tzakis, A.; Martin, M.; Selby, R.; Bronsther, O.; Doyle, H.; Gayowski, T. 1993: Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine Transplantation Proceedings 25(1 Part 2): 1130
Steininger, R.; Herbst, F.; Függer, R.; Mühlbacher, F.; Fritsch, A. 1992: Immunosuppression does not enhance tumor growth after orthotopic liver transplantation for hepatoma Transplantation Proceedings 24(6): 2690-2692
Tinti, F.; Mitterhofer, A.P.; Muiesan, P. 2012: Liver transplantation: role of immunosuppression, renal dysfunction and cardiovascular risk factors Minerva Chirurgica 67(1): 1-13
Papatheodoridis, G.V.; Davies, S.; Dhillon, A.P.; Teixeira, R.; Goulis, J.; Davidson, B.; Rolles, K.; Dusheiko, G.; Burroughs, A.K. 2001: The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis Transplantation 72(3): 412-418
Lemmens, H.P.; Langrehr, J.M.; Bechstein, W.O.; Blumhardt, G.; Keck, H.; Lüsebrink, R.; Knoop, M.; Lohmann, R.; Tullius, S.; Lobeck, H. 1995: Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trial Transplantation Proceedings 27(1): 1140-1141
Karasu, Z.; Ozacar, T.; Akyildiz, M.; Demirbas, T.; Arikan, C.; Kobat, A.; Akarca, U.; Ersoz, G.; Gunsar, F.; Batur, Y.; Kilic, M.; Tokat, Y. 2004: Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation Antiviral Therapy 9(6): 921-927
Carter, J.L.; Hafler, D.A.; Dawson, D.M.; Orav, J.; Weiner, H.L. 1988: Immunosuppression with high-dose I.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients Neurology 38(7 Suppl 2: 9-14
Lerut, J.; Stieber, A.C.; Makowka, L.; Esquivel, C.O.; Iwatsuki, S.; Gordon, R.D.; Starzl, T.E. 1989: Long-term results of orthotopic liver transplantation during the cyclosporin era. 393 orthotopic liver transplantations accomplished in 313 consecutive patients at the Pittsburgh Transplantation Center Helvetica Chirurgica Acta 56(3): 405-420
Whiting, J.F.; Fecteau, A.; Martin, J.; Bejarano, P.A.; Hanto, D.W. 1998: Use of low-dose OKT3 as induction therapy in liver transplantation Transplantation 65(4): 577-580
Zeevi, A.; Eiras, G.; Burckart, G.; Jain, A.; Kragack, A.; Venkataramanan, R.; Todo, S.; Fung, J.; Starzl, T.E.; Duquesnoy, R.J. 1990: Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression Transplantation Proceedings 22(1): 60-63
Gugenheim, J.; Samuel, D.; Saliba, F.; Castaing, D.; Bismuth, H. 1988: Use of cyclosporine a in combination with low-dose corticosteroids and azathioprine in liver transplantation Transplantation Proceedings 20(3 Suppl 3: 366-368
van Laar, J.M.; Verburg, R.J.; Fibbe, W.E.; Breedveld, F.C. 2001: Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: the Leiden experience Journal of Rheumatology. Supplement 64: 25-27
Hökl, J.; Cerný, J.; Nĕmec, P. 1995: Advances in transplantation biology and transplantation of vital organs in the era of immunosuppression with cyclosporin a Casopis Lekaru Ceskych 134(24): 775-778